Mind Medicine (MindMed) Inc.
NASDAQ Capital MarketTotal Valuation
Mind Medicine (MindMed) Inc. carries a market capitalization of 1.56B, placing it among publicly traded companies globally. Its enterprise value stands at 834.15M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.56B |
| Enterprise Value | 834.15M |
Share Statistics
Mind Medicine (MindMed) Inc. currently has 76.77M shares outstanding.
| Shares Outstanding | 76.77M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -1.88 |
| P/TBV Ratio | 9.06 |
| P/FCF Ratio | -8.85 |
| P/OCF Ratio | -8.80 |
Financial Position
Mind Medicine (MindMed) Inc. maintains a current ratio of 3.30, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 30.92, indicating elevated leverage, while an interest coverage ratio of -31.05 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.30 |
| Quick Ratio | 3.20 |
| Debt / Equity | 30.92 |
| Debt / EBITDA | -0.27 |
| Interest Coverage | -31.05 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -60.39 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Mind Medicine (MindMed) Inc.'s stock has gained approximately 198.557% over the past 52 weeks. The 50-day moving average sits at 12.71, while the 200-day moving average is 9.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | 198.557% |
| 50-Day Moving Average | 12.71 |
| 200-Day Moving Average | 9.85 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -151.19M, while operating income came in at -151.19M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -151.19M |
| Pretax Income | -168.10M |
| Net Income | -168.10M |
| EBITDA | -151.19M |
| EBIT | -151.19M |
| Earnings Per Share (EPS) | -1.96 |
Balance Sheet
Mind Medicine (MindMed) Inc. holds 209.07M in cash and equivalents against 40.39M in total debt, resulting in a net debt position of 20.43M. Total book value stands at -532.24M, with working capital of 150.43M providing operational flexibility.
| Cash & Cash Equivalents | 209.07M |
| Total Debt | 40.39M |
| Net Debt | 20.43M |
| Equity (Book Value) | -532.24M |
| Book Value Per Share | -6.26 |
| Working Capital | 150.43M |
Cash Flow
Mind Medicine (MindMed) Inc. produced -113.94M in operating cash flow over the past twelve months.
| Operating Cash Flow | -113.94M |
| Capital Expenditures | N/A |
| Free Cash Flow | -113.94M |
| FCF Per Share | -1.34 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -2.51 |
| FCF Yield | -11.29 |
Stock Splits
Mind Medicine (MindMed) Inc.'s most recent stock split took place on August 29, 2022 with a 15:1 split ratio.
| Last Split Date | 8/29/2022 |
| Split Ratio | 15:1 |
Scores
Mind Medicine (MindMed) Inc. posts an Altman Z-Score of 0.76, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.76 |